Regulatory PathRegulatory requirements compared

Active substances

Desogestrel + Ethinylestradiol

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CYBELLE FILM COATED TABLET30,150 µg,µgFilm-coated tablet · Oral use28 BlisterSAR 10.20Generic · PrescriptionExeltis Healthcare S.LValid
GRACIAL TABLET0.025,0.03 mg,mgTablet · Oral use22 BlisterSAR 19.60Generic · PrescriptionASPEN PHARMA TRADING LIMITED (APTL)Valid
MARVELON TAB150,30 µg,µgTablet · Oral use21 BlisterSAR 14.60Generic · PrescriptionORGANONValid
REGULON150,30 µg,µgFilm-coated tablet · Oral use21 BlisterSAR 10.20Generic · PrescriptionAJA PHARMACEUTICAL INDUSTRIESValid
GRACIAL TABLET0.03, 0.025 mgTablet · Oral use22 BlisterSAR 21.85Generic · PrescriptionORGANONWithdrawn by MAH · Not Marketed
MARVELON TAB30, 150 µgTablet · Oral use63 BlisterSAR 32.65Generic · PrescriptionORGANONWithdrawn by MAH · Not Marketed
REGULON30, 150 µgFilm-coated tablet · Oral use63 BlisterSAR 22.85Generic · PrescriptionAJA PHARMACEUTICAL INDUSTRIESWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

CONTRACEPTION; ENDOMETRIOSIS; HYPERPROLACTINEMIA; MENOPAUSE; MENSTRUAL DISORDERS

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG;0.03MGtablet · oral-28DURAMED PHARMS BARRPrescription12 Aug 1999
CYCLESSA0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MGtablet · oral-28ASPEN GLOBAL INCPrescription20 Dec 2000
KARIVA0.15MG,N/A;0.02MG,0.01MGtablet · oral-28BARRPrescription5 Apr 2002
VELIVET0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MGtablet · oral-28DURAMED PHARMS BARRPrescription24 Feb 2004
DESOGESTREL; ETHINYL0.125MG/0.025MG; 0.15MG/0.025MGtablet · oralDURAMED PHARMS BARRPrescription24 Feb 2004
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG;0.03MGtablet · oral-28WATSON LABSPrescription29 Jul 2005
DESOGESTREL; ETHINYL ESTRADIOL0.125MG/0.025MG; 0.15MG/0.025MGtablet · oral-28DR REDDYS LABS SAPrescription24 Jan 2006
VIORELE0.15MG,N/A;0.02MG,0.01MGtablet · oral-28GLENMARK PHARMS LTDPrescription2 Apr 2012
ENSKYCE0.15MG;0.03MGtablet · oral-28LUPIN LTDPrescription7 Mar 2013
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG;0.03MGtablet · oral-28NOVAST LABSPrescription12 Jul 2013
PIMTREA0.15MG,N/A;0.02MG,0.01MGtablet · oral-28NOVAST LABSPrescription1 Aug 2013
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG,N/A;0.02MG,0.01MGtablet · oral-28XIROMEDPrescription30 Aug 2013
BEKYREE0.15MG,N/A;0.02MG,0.01MGtablet · oral-28LUPINPrescription12 Aug 2015
ISIBLOOM0.15MG;0.03MGtablet · oral-28XIROMEDPrescription12 Aug 2015
VOLNEA0.15MG,N/A;0.02MG,0.01MGtablet · oral-28XIROMEDPrescription9 Sep 2016
SIMLIYA0.15MG,N/A;0.02MG,0.01MGtablet · oral-28AUROBINDO PHARMAPrescription22 Mar 2017
KALLIGA0.15MG;0.03MGtablet · oral-28AUROBINDO PHARMAPrescription17 May 2017
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG,N/A;0.02MG,0.01MGtablet · oral-28NAARI PTEPrescription5 Jun 2017
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG;0.03MGtablet · oral-28NAARI PTEPrescription13 Sep 2018
AVERI0.15MG;0.03MGtablet · oral-21AVION PHARMSPrescription2 May 2025
AVERI0.15MG;0.03MGtablet · oral-28AVION PHARMSPrescription2 May 2025
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG;0.03MGtablet · oral-28ANNORA PHARMAPrescription18 Mar 2026
DESOGESTREL AND ETHINYL ESTRADIOL0.15MG,N/A;0.02MG,0.01MGtablet · oral-28ANNORA PHARMAPrescription7 Jul 2026
DESOGEN0.15MG;0.03MGtablet · oral-21ORGANON USA INCDiscontinued10 Dec 1992
DESOGEN0.15MG;0.03MGtablet · oral-28ORGANON USA INCDiscontinued10 Dec 1992

9 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
APRI 21023171920.15 MG; 0.03 MGTABLET · ORALTEVA CANADA LIMITED
APRI 28023172060.03 MG; 0.15 MGTABLET · ORALTEVA CANADA LIMITED
FREYA 21023964910.15 MG; 0.03 MGTABLET · ORALSENADOR LABORATORIES PRIVATE LIMITED
FREYA 28023966100.03 MG; 0.15 MGTABLET · ORALSENADOR LABORATORIES PRIVATE LIMITED
LINESSA 21022729030.025 MG; 0.15 MG; 0.125 MG; 0.1 MGTABLET · ORALASPEN PHARMACARE CANADA INC.
LINESSA 28022572380.1 MG; 0.025 MG; 0.125 MG; 0.15 MGTABLET · ORALASPEN PHARMACARE CANADA INC.
MARVELON 21020424870.15 MG; 0.03 MGTABLET · ORALORGANON CANADA INC.
MARVELON 28020424790.15 MG; 0.03 MGTABLET · ORALORGANON CANADA INC.
MILEY 21025565530.15 MG; 0.03 MGTABLET · ORALAMBICARE PHARMACEUTICALS INC.
MILEY 28025565610.03 MG; 0.15 MGTABLET · ORALAMBICARE PHARMACEUTICALS INC.
MIRVALA 21024102490.1500 MG / TAB; 0.0300 MG / TABTABLET · ORALAPOTEX INC
MIRVALA 28024102570.1500 MG / TAB; 0.0300 MG / TABTABLET · ORALAPOTEX INC

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACENSKYCE 28 TABLET$0.13531per EA23 Sep 2026
US NADACISIBLOOM 28 DAY TABLET$0.13531per EA23 Sep 2026
US NADACKARIVA 28 DAY TABLET$0.17245per EA23 Sep 2026
US NADACPIMTREA 28 DAY TABLET$0.17245per EA23 Sep 2026
US NADACSIMLIYA 28 DAY TABLET$0.17245per EA23 Sep 2026
US NADACVELIVET 28 DAY TABLET$0.53646per EA23 Sep 2026
US NADACVIORELE 28 DAY TABLET$0.17245per EA23 Sep 2026
US NADACVOLNEA 0.15-0.02-0.01 MG TAB$0.17245per EA23 Sep 2026
NHS Drug TariffEthinylestradiol 20microgram / Desogestrel 150microgram tablets£5.9863 tablet1 Oct 2026
NHS Drug TariffEthinylestradiol 30microgram / Desogestrel 150microgram tablets£4.9363 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.